Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 312.00M | 320.00M | 252.00M | 245.00M | 245.00M |
| Total Depreciation and Amortization | 147.00M | 146.00M | 147.00M | 145.00M | 142.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 153.00M | 43.00M | 89.00M | 11.00M | 155.00M |
| Change in Net Operating Assets | -1.00M | 88.00M | -210.00M | 64.00M | 21.00M |
| Cash from Operations | 611.00M | 597.00M | 278.00M | 465.00M | 563.00M |
| Capital Expenditure | -166.00M | -138.00M | -114.00M | -158.00M | -144.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.00M | 0.00 | -38.00M | -50.00M | -34.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | 4.00M | -- | 17.00M | -23.00M |
| Cash from Investing | -169.00M | -134.00M | -152.00M | -191.00M | -201.00M |
| Total Debt Issued | 0.00 | 494.00M | -- | 0.00 | 10.00M |
| Total Debt Repaid | -3.00M | -500.00M | -1.00M | -1.00M | -10.00M |
| Issuance of Common Stock | 27.00M | 16.00M | 65.00M | 18.00M | 19.00M |
| Repurchase of Common Stock | -152.00M | -103.00M | -37.00M | -301.00M | -152.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -95.00M | -96.00M | -88.00M | -90.00M | -89.00M |
| Other Financing Activities | -48.00M | -40.00M | -91.00M | 87.00M | -25.00M |
| Cash from Financing | -271.00M | -229.00M | -152.00M | -287.00M | -247.00M |
| Foreign Exchange rate Adjustments | 0.00 | -1.00M | -1.00M | 1.00M | -2.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.00M | 233.00M | -27.00M | -12.00M | 113.00M |